Dare Bioscience, Inc. (DARE) vs Passage Bio, Inc. (PASG)
A side-by-side comparison of Dare Bioscience, Inc. and Passage Bio, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
DARE
Dare Bioscience, Inc.
$0.84HealthcareDelayed quote: Oct 6, 2026, 3:16 PM EDT
PASG
Passage Bio, Inc.
$3.98HealthcareDelayed quote: Oct 6, 2026, 3:18 PM EDT
Total return — DARE vs PASG
growth of $100 · dividends reinvested · last 7yDARE -94.0% (-33.1%/yr)PASG -99.1% (-48.8%/yr)DARE compounded faster over this window
Log scale — wide-divergence pair
DARE PASG
DARE vs PASG: by the numbers
- •PASG is the larger company ($13M vs $13M market cap).
- •Both run net losses; PASG's is the smaller (0.00% vs -804.37% net margin).
Metrics side by side
Valuation
| Metric | DARE | PASG |
|---|---|---|
| P/S ratio | 9.19 | N/A |
| P/B ratio | N/A | 2.87 |
Profitability
| Metric | DARE | PASG |
|---|---|---|
| Gross margin | -137.55% | 0.00% |
| Operating margin | -1315.51% | 0.00% |
| Net margin | -804.37% | 0.00% |
| ROE | N/A | -810.41% |
| ROIC | -203.50% | -889.92% |
Growth (annualized)
| Metric | DARE | PASG |
|---|---|---|
| Total return CAGR (5Y) | -46.35% | -53.23% |
Frequently asked
- How have DARE and PASG total returns compared?
- Over the past 5 years, DARE delivered -46.35% and PASG delivered -53.23% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.